X
Please Wait
Applying Filters...
01 IMATINIB MESYLATE (2)
02 Imatinib Mesylate (1)
01 AqVida GmbH (1)
02 NOVARTIS (2)
01 CAPSULE (1)
02 CAPSULE;ORAL (2)
01 200MG (1)
02 EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
03 EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
01 Germany (1)
02 USA (2)
19
AqVida GmbH, based in Germany, is a pharmaceutical company.
One of their notable products is Imatinib Mesylate, with a corresponding application number 21335 and regulatory information .
proudly manufactured in the
AqVida GmbH's CAPSULE, medication with 200MG of Imatinib Mesylate.
18
Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is IMATINIB MESYLATE, with a corresponding application number 21335 and regulatory information .
proudly manufactured in the
approval since 2001-05-10
Novartis Pharmaceuticals Corporation's GLEEVEC CAPSULE;ORAL, medication with EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of IMATINIB MESYLATE.
17
Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is IMATINIB MESYLATE, with a corresponding application number 21335 and regulatory information .
proudly manufactured in the
approval since 2001-05-10
Novartis Pharmaceuticals Corporation's GLEEVEC CAPSULE;ORAL, medication with EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of IMATINIB MESYLATE.
Market Place
